Which interaction is central to osteoclast activation by osteoblasts in normal bone remodeling?

Which interaction is central to osteoclast activation by osteoblasts in normal bone remodeling?

• A. RANKL binding to RANK on osteoclast precursors
• B. Osteoprotegerin binding to RANKL
• C. M-CSF binding to CSF1 receptor
• D. IL-6 binding to IL-6 receptor

Answer: (A)

In normal bone remodeling, osteoblasts control osteoclast activity through the RANKL–RANK system. Osteoblasts express RANKL, which binds to the RANK receptor on osteoclast precursors. This interaction triggers signaling that promotes differentiation into mature, active osteoclasts and drives their bone-resorbing function. Osteoprotegerin can bind RANKL as a decoy, dampening this activation, while M-CSF supports precursor survival and differentiation but is not the direct activation signal. IL-6 can influence osteoclast formation in inflammation, but it isn’t the central mechanism under normal remodeling. Therefore, the pivotal interaction is RANKL binding to RANK on osteoclast precursors.

In normal bone remodeling, osteoblasts control osteoclast activity through the RANKL–RANK system. Osteoblasts express RANKL, which binds to the RANK receptor on osteoclast precursors. This interaction triggers signaling that promotes differentiation into mature, active osteoclasts and drives their bone-resorbing function. Osteoprotegerin can bind RANKL as a decoy, dampening this activation, while M-CSF supports precursor survival and differentiation but is not the direct activation signal. IL-6 can influence osteoclast formation in inflammation, but it isn’t the central mechanism under normal remodeling. Therefore, the pivotal interaction is RANKL binding to RANK on osteoclast precursors.